Interferon alfa-2a biosimilar (Pharmedic Laboratories)

干扰素α-2b生物类似药 (Pharmedic Laboratories)

Report date: 2022/02/10 10:43:38

Base Information

Drug NameInterferon alfa-2a biosimilar (Pharmedic Laboratories)
Drug Alias Name干扰素α-2b生物仿制药 (Pharmedic Laboratories)hepaferon
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis
Global Approved IndicationsHepatitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2013/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPharmedic Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesPharmedic Laboratories
Inactive CompaniesN/A
Active IndicationsHepatitis
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A